Sintx Technologies (NASDAQ:SINT – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $10.00 price objective on the stock. HC Wainwright’s target price would suggest a potential upside of 354.55% from the stock’s current price.
Several other equities analysts also recently issued reports on the stock. Ascendiant Capital Markets decreased their price objective on shares of Sintx Technologies from $16.00 to $12.00 and set a “buy” rating for the company in a research note on Wednesday, April 8th. Weiss Ratings restated a “sell (e+)” rating on shares of Sintx Technologies in a research note on Tuesday, April 21st. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Sintx Technologies has an average rating of “Hold” and a consensus price target of $11.00.
Read Our Latest Analysis on Sintx Technologies
Sintx Technologies Trading Down 1.3%
Sintx Technologies (NASDAQ:SINT – Get Free Report) last released its quarterly earnings data on Friday, May 15th. The company reported ($0.70) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.66) by ($0.04). Sintx Technologies had a negative return on equity of 366.49% and a negative net margin of 1,058.60%.The company had revenue of $0.38 million for the quarter, compared to analyst estimates of $0.30 million. On average, equities research analysts predict that Sintx Technologies will post -2.16 earnings per share for the current year.
Hedge Funds Weigh In On Sintx Technologies
An institutional investor recently raised its position in Sintx Technologies stock. Geode Capital Management LLC boosted its stake in Sintx Technologies, Inc. (NASDAQ:SINT – Free Report) by 33.5% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,339 shares of the company’s stock after acquiring an additional 3,848 shares during the period. Geode Capital Management LLC owned 0.56% of Sintx Technologies worth $49,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 18.38% of the company’s stock.
Sintx Technologies Company Profile
Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.
The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.
Read More
- Five stocks we like better than Sintx Technologies
- Palo Alto Networks Up 70%: Can the Rally Last Into June?
- Block’s Pivot to Profits and AI Is Turning Heads
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
